A new blood test could detect early stage melanoma in more than 80% of patients

July 18, 2018 by Mel Ziman, The Conversation

Blood can tell us a lot about our health. Credit: www.shutterstock.com
Melanoma kills more than 1,700 Australians every year, which is more than the national road toll. But the good news is it's treatable if caught early enough. And a new blood test might be able to help with faster and easier diagnosis.

Currently, is diagnosed by an examination of the skin by trained clinicians. Once a lesion is classified as abnormal, a of the lesion is performed and sent to a pathology laboratory for diagnosis.

Most biopsies (75%) will come back negative, so this is a significant cost to the health system. And biopsies are invasive, requiring excision of the skin under local anaesthetic.

Diagnosis is challenging, particularly in cases of small, thin, early-stage melanomas; in with more than 100 moles; and in cases of amelanotic tumours (which don't have a colour). A test prior to a biopsy could provide diagnostic certainty, particularly in high-risk patients.

The new blood test

We set out to find ways in which we could detect melanoma by screening patients' blood. We discovered antibodies produced by the body in response to melanoma, and found these could be detected in blood.

Because the body starts producing these antibodies as soon as the melanoma first develops, the blood test is able to detect the cancer early in its progression.

A total of 1,627 different types of antibodies were examined to identify a combination of the ten antibodies that best indicated the presence of melanoma.Using an Oxford Gene Technology Array which allows us to identify proteins such as antibodies, we analysed the blood of 105 melanoma patients and 104 healthy people, to compare.

We found 139 possible antibodies that were expressed at higher levels in the patients with melanoma when compared to healthy people. Using high level statistical analyses we identified a combination of ten autoantibodies (what the body uses to fight illness) that can detect melanoma in early stage patients 79% of the time.

So how far away is this test from the clinic?

Before we can start using this blood tests on patients in the clinic, there are a few steps we have to take first. While our results have been positive in our first round of testing, we need to test more patients to be sure.

We'll perform a clinical trial involving 1,000 participants, where we'll collect blood from patients when a doctor has ordered a biopsy due to a suspicious lesion. We can compare our test results to the biopsy results and we'll be able to identify how accurate our test is, and improve its accuracy to 90%, which is what should be expected of medical diagnostic testing.

By testing more people we hope to find more, or better, , and this will bring up the accuracy rate.

We hope to have this completed in three years, and then we'll work with a commercial company to license a product that can process the tests in clinics.

Hopefully in the not-too-distant future, when a suspicious lesion is identified in a patient, rather than having to undergo a biopsy, patients can just have a simple .

A negative test would give doctors an additional tool to have more diagnostic certainty prior to a biopsy. Biopsies would be required if a test comes back positive.

Many people are aware suspicious lesions found on skin checks will mean they have to undergo a biopsy, and so they may avoid getting checked. This could alleviate patient concern over skin checks, and allow people in rural and remote areas to get an earlier and more accessible diagnosis.

Explore further: Scientists develop 'world first' melanoma blood test

Related Stories

Scientists develop 'world first' melanoma blood test

July 18, 2018
Australian researchers said Wednesday they have developed a blood test for melanoma in its early stages, calling it a "world first" breakthrough that could save many lives.

The role of smartphones in skin checks for early detection of melanoma

September 7, 2017
QUT skin cancer researchers are seeking community volunteers to participate in a skin self-examination study. Performed regularly, self-examination can alert you to changes in your skin and may improve the early detection ...

Using virtual biopsies to improve melanoma detection

May 18, 2018
With Skin Cancer Awareness Month upon us, Colorado State University researcher Jesse Wilson is accelerating research to improve imaging and detection of melanoma, the most deadly form of skin cancer, and the fifth most common ...

PAs may have lower diagnostic accuracy for melanoma

April 20, 2018
(HealthDay)—Physician assistants (PAs) perform more skin biopsies per case of skin cancer diagnosed and diagnose fewer melanomas in situ than dermatologists, according to a study published online April 18 in JAMA Dermatology.

New guidelines may slightly increase reliability, accuracy of melanoma diagnoses

May 21, 2018
In a new study, researchers have developed updated guidelines for classifying a serious form of skin cancer called invasive melanoma. The American Joint Committee on Cancer, an organization that provides information on "cancer ...

Recommended for you

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

October 12, 2018
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to ...

Researchers find a 'critical need' for whole genome sequencing of young cancer patients

October 12, 2018
St. Jude Children's Research Hospital has re-defined the gold standard for diagnostic testing of childhood cancer patients in the precision-medicine era and has implemented the testing for new cancer patients. The findings ...

Immune cells in triple-negative breast cancer offer potential therapeutic target

October 11, 2018
About 15 percent of breast cancers are classified as triple-negative, lacking receptors for estrogen, progesterone, and Her2. These cancers do not respond to targeted hormonal therapies, and they tend to be particularly aggressive, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.